CIK: 0001410830 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 13, 2026
Total Value ($000): $57,616 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 13,959,973 | $21,080 | 36.6% | $29.98 | -95.1% | — | 98943L107 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MAZE | MAZE THERAPEUTICS INC | 480,000 (-71.0%) | $19,886 (-53.6%) | 34.5% | $12.04 | +185.5% | COM | 578784100 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AURA | AURA BIOSCIENCES INC | 6,922,870 | $37,730 | 65.5% | $14.82 | -59.9% | COM | 05153U107 |